Oxford Immune Algorithmics
PrivateLast Round
Grant
Nov 6, 2022
Est. Valuation
$67.78M
Total Funding Raised
$14.07M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Oxford Immune Algorithmics is a health technology company that develops Algocyte, a platform for predictive and personalized healthcare through remote immune system monitoring.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical AI, Precision Medicine, Healthcare Analytics, Clinical Trials
Business Model
B2B
Customer Profile
Hardware + Subscription, Usage-Based SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Oxford Immune Algorithmics Comparables
Compare Oxford Immune Algorithmics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Soulbrain Holdings Co. Ltd | 77% | |
| Commure | 71% | |
| Sight Diagnostics | 70% | |
Oxford Immune Algorithmics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Nov 6, 2022 | ||||
| Series A | Mar 6, 2021 | ||||
| Seed | Dec 17, 2020 | ||||
| Seed | Apr 28, 2020 |
Key People
Founding team and executive leadership
Oxford Immune Algorithmics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| EPSRC | Grant |
| MedTech AI Inc. | Series A |
| SFC Capital | Series A, Seed |
| Kin Capital | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors grew 108% MoM.
- Nov 4, 2025
Showcased at New Scientist Live, the UK's largest science event.
Oxford Immune Algorithmics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Oxford Immune Algorithmics's valuation, stock price, and market status.